📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ZymoGenetics

1.1 - Company Overview

ZymoGenetics Logo

ZymoGenetics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapeutic protein discovery, development, and early manufacturing, supported by fully integrated research and development capabilities in scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, and clinical expertise; with an early focus on production systems for recombinant proteins.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ZymoGenetics

Omni Biopharma Logo

Omni Biopharma

HQ: United States Website
  • Description: Provider of Alpha-1 antitrypsin (AAT)-based therapeutics, developing alternative uses of AAT for various medical treatments and advancing recombinant forms of AAT for therapeutic applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Omni Biopharma company profile →
KalVista Pharmaceuticals Logo

KalVista Pharmaceuticals

HQ: United States Website
  • Description: Provider of oral plasma kallikrein inhibitors for on-demand treatment of hereditary angioedema (HAE), including Sebetralstat being evaluated in the KONFIDENT Phase 3 Trial; developer of oral Factor XIIa inhibitors to prevent thrombosis with reduced bleeding risk; and other oral therapies targeting the kallikrein-kinin system, including HAE. An ophthalmology company with a focus on diabetic macular edema (DME).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full KalVista Pharmaceuticals company profile →
Noven Pharmaceuticals Logo

Noven Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty prescription pharmaceutical products, engaged in the research, development, manufacture, marketing and sale of these products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Noven Pharmaceuticals company profile →
Zealand Pharma Logo

Zealand Pharma

HQ: Denmark Website
  • Description: Provider of peptide-based medicines and novel specialty drug candidates, leveraging leading-edge expertise and partnerships. Offerings include dasiglucagon for severe hypoglycemia (with Novo Nordisk), survodutide for obesity and MASH (with Boehringer Ingelheim), dapiglutide, and devices such as the investigational bihormonal iLet bionic pancreas (with Beta Bionics) and a continuous infusion pump for congenital hyperinsulinism (with DEKA Research).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zealand Pharma company profile →
ZS Pharma Logo

ZS Pharma

HQ: United States Website
  • Description: Provider of highly selective ion-trap therapies and therapeutic candidates to treat serious, life-threatening conditions, including hyperkalemia and liver diseases; a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA, focused on R&D, with ZS-9 as a novel treatment candidate for hyperkalemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ZS Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ZymoGenetics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ZymoGenetics

2.2 - Growth funds investing in similar companies to ZymoGenetics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ZymoGenetics

4.2 - Public trading comparable groups for ZymoGenetics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ZymoGenetics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ZymoGenetics

What does ZymoGenetics do?

ZymoGenetics is a provider of therapeutic protein discovery, development, and early manufacturing, supported by fully integrated research and development capabilities in scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, and clinical expertise; with an early focus on production systems for recombinant proteins.

Who are ZymoGenetics's competitors?

ZymoGenetics's competitors and similar companies include Omni Biopharma, KalVista Pharmaceuticals, Noven Pharmaceuticals, Zealand Pharma, and ZS Pharma.

Where is ZymoGenetics headquartered?

ZymoGenetics is headquartered in United States.

How many employees does ZymoGenetics have?

ZymoGenetics has 1,000 employees 🔒.

When was ZymoGenetics founded?

ZymoGenetics was founded in 2010 🔒.

What sector and industry vertical is ZymoGenetics in?

ZymoGenetics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ZymoGenetics

Who are the top strategic acquirers in ZymoGenetics's sector and industry

Top strategic M&A buyers and acquirers in ZymoGenetics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ZymoGenetics?

Top strategic M&A buyers groups and sectors for ZymoGenetics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ZymoGenetics's sector and industry vertical

Which are the top PE firms investing in ZymoGenetics's sector and industry vertical?

Top PE firms investing in ZymoGenetics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ZymoGenetics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ZymoGenetics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ZymoGenetics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ZymoGenetics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ZymoGenetics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ZymoGenetics?

The key public trading comparables and valuation benchmarks for ZymoGenetics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ZymoGenetics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ZymoGenetics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ZymoGenetics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ZymoGenetics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ZymoGenetics's' sector and industry vertical?

Access recent funding rounds and capital raises in ZymoGenetics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ZymoGenetics